ETN NewsNews. Trust. Impact.
India

Trump's Pharma Tariffs Spare Generics, Leave India's Specialty Drugmakers Exposed

06 Apr 2026, 06:54 am
The US has imposed tariffs of up to 100% on patented pharmaceuticals, with significant carve-outs for generics, biosimilars, and major manufacturing hubs, leaving India's speciality drugmakers exposed while generic players remain unscathed.
0Likes
0Dislikes
Related Coverage

More stories from ETN

Latest curated coverage